As we kick off this year’s The Society of Thoracic Surgeons Annual Meeting, our thoughts are with those impacted by the ongoing California wildfires in the LA area. At AtriCure, we’re dedicated to supporting our communities, and our Bay Area team joined Kids Against Hunger to pack meals for first responders and affected families while we continue to fundraise for relief efforts.

This weekend, we’re also focused on advancing care by connecting with thoracic and cardiac surgeons from around the globe. If you’re at <a href='https://www.linkedin.com/feed/hashtag/?keywords=STS2025&highlightedUpda…; target='_blank'>#STS2025</a>, visit us at booth 705 to explore the latest in LAA exclusion, Afib treatment, and post-op pain management—or stop by booth 813 for hands-on training in our surgical suite.

The Isolator® Synergy™ EnCompass® Clamp simplifies ablations by reducing tissue dissection for easier placement.​

With 22,000+ cases performed using the EnCompass Clamp, cardiac surgeons continue to recognize its innovative design.​

Discover why:<a href="https://t.co/3Rzg81azzU&quot; target="_blank">https://t.co/3Rzg81azzU</a&gt;… <a href="https://t.co/bOmN6VEDhZ&quot; target="_blank">https://t.co/bOmN6VEDhZ</a&gt;

The Isolator® Synergy™ EnCompass® Clamp simplifies the ablation process by reducing tissue dissection for easier placement.​

With over 22,000 cases performed using the EnCompass Clamp, cardiac surgeons continue to recognize its innovative design.​

Learn how the EnCompass Clamp could transform your practice: <a href="https://okt.to/6Kc9qk&quot; target="_blank">https://okt.to/6Kc9qk</a&gt; ​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Ablation&highlightedUpd…; target='_blank'>#Ablation</a>​

Hear the latest about ongoing &amp; completed clinical trials in arrhythmia and LAAM on Saturday at <a href="https://twitter.com/hashtag/STS2025?src=hashtag_click&quot; target="_blank">#STS2025</a> to hear from leading experts who examine the latest clinical trial data &amp; real-world experiences of transformational treatment strategies. Register at: <a href="https://t.co/zhmBymooAF&quot; target="_blank">https://t.co/zhmBymooAF</a&gt;

Want to learn the latest about ongoing and completed clinical trials in arrhythmia and LAA management? Join Saturday at <a href='https://www.linkedin.com/feed/hashtag/?keywords=STS2025&highlightedUpda…; target='_blank'>#STS2025</a> to hear from leading experts who examine the latest clinical trial data and real-world experiences of transformational treatment strategies. Registration is open at: <a href="https://okt.to/a8fnRs&quot; target="_blank">https://okt.to/a8fnRs</a&gt;

As pain management and technology evolve, so should the ways we measure it. Explore how assessing functional pain and transitional pain can make a meaningful difference in post-op recovery outcomes.​

Learn more: <a href="https://t.co/4NdglXl2Ow&quot; target="_blank">https://t.co/4NdglXl2Ow</a&gt; ​

<a href="https://twitter.com/hashtag/PainManagement?src=hashtag_click&quot; target="_blank">#PainManagement</a>

Pain levels can fluctuate based on activity—whether lifting a box or sitting still, the experience of pain changes. As pain management and technology evolve, so should the ways we measure it. Explore how assessing functional pain and transitional pain can make a meaningful difference in post-op recovery outcomes.​

Learn more: <a href="https://okt.to/lPSn4Z&quot; target="_blank">https://okt.to/lPSn4Z</a&gt; ​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=PainManagement&highligh…; target='_blank'>#PainManagement</a>​

After hybrid ablation and LAAE with AtriClip®,​ overall, 62.4% of patients with more advanced forms of Afib* remained free from atrial arrhythmias** at 2 years of follow-up in the DEEP Trial.

*Persistent or long-standing persistent Afib. ​
*Effectiveness was freedom from Afib,… <a href="https://t.co/43bmVIgmjs&quot; target="_blank">https://t.co/43bmVIgmjs</a&gt;

After hybrid ablation and left atrial appendage exclusion with AtriClip®,​ overall, 62.4% of patients with more advanced forms of Afib* remained free from atrial arrhythmias** at 2 years of follow-up in the DEEP Trial. ​​

*Persistent or long-standing persistent Afib.​
*Effectiveness was freedom from Afib, atrial flutter, atrial tachycardia (>30 sec); absent new/increased dose of previously failed class I/III anti-arrhythmic drugs.

We honor the legacy of Dr. Martin Luther King Jr., whose words remind us that love and light have the power to create lasting change. At AtriCure, we are committed to fostering kindness, understanding, and inclusivity in all we do. <a href="https://twitter.com/hashtag/MLKDay?src=hashtag_click&quot; target="_blank">#MLKDay</a>